Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gabel

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen ChlamydiaKaruna P Karunakaran, Jose Rey-Ladino, Nikolay Stoynov, et al.
Journal of Lipid Research|August 1, 1997
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disordersY Y van der Hoek, R J Wanders, A E van den Ende, et al.
Biochemistry|August 26, 1997
The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surfaceW Sangrar, B R Gabel, M B Boffa, et al.
Archives of Biochemistry and Biophysics|April 2, 2003
A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidationBruce C Hill, Lev Becker, Vijay Anand, et al.
Circulation|August 16, 2000
CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cellsN S Haque, X Zhang, D L French, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonistM Nishikibe, H Ohta, M Okada, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen ChlamydiaKaruna P Karunakaran, Jose Rey-Ladino, Nikolay Stoynov, et al.
Journal of Lipid Research|August 1, 1997
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disordersY Y van der Hoek, R J Wanders, A E van den Ende, et al.
Biochemistry|August 26, 1997
The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surfaceW Sangrar, B R Gabel, M B Boffa, et al.
Archives of Biochemistry and Biophysics|April 2, 2003
A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidationBruce C Hill, Lev Becker, Vijay Anand, et al.
Circulation|August 16, 2000
CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cellsN S Haque, X Zhang, D L French, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonistM Nishikibe, H Ohta, M Okada, et al.
Pageof 7